The relationships between primary human immunodeficiency virus type 1 (HIV-1) Gag -specific cytotoxic T lymphocyte (CTL) frequency, virus load, and CD4 T cell loss were evaluated in a group of 46 HIV-1 -infected persons with hemophilia. Freshly isolated peripheral blood mononuclear cells in limiting dilution assays were used to measure HIV-1 Gag -specific CTL frequencies. Concurrent measurements of virus load and lymphocyte surface markers were obtained. No correlation between Gag-specific CTL frequency and concurrent CD4 cell count was observed. A significant inverse relationship was observed between HIV-1 Gag -specific CTL frequency and provirus load as measured by polymerase chain reaction. Subjects with higher CTL frequencies were found to have more stable CD4 cell counts over time. These results provide additional evidence to support the concept that the predominant role of this virus-specific cellular immune response is to limit viral replication and CD4 cell loss in HIV-1 infection.
A vigorous cytotoxic T lymphocyte (CTL) response is genercells [18] . Significant effects may also result from cytokines released on CTL activation [19] . These act locally, but less ated in most adults with human immunodeficiency virus type 1 (HIV-1) infection [1 -6] . Compared with that occurring in specifically, and bystander (uninfected, neighboring) cells may also be affected [20] . Cytokines elaborated by CTL include other chronic viral infections, this immune response is unique with respect to its breadth, magnitude, and durability. The specinterferon-g and tumor necrosis factors-a and -b. Each of these could contribute to positive or negative regulation of virus trum of CTL specificities observed in seropositive persons includes most structural and regulatory proteins of HIV-1 expression in infected cells, depending on the cell type. Uninfected cells may also respond to these cytokines with resultant [3, 7 -10]. Circulating major histocompatibility complex class I -restricted, CD8-positive, ''primary'' HIV-1 -specific CTL immunopathology [21] . Finally, CD8-positive cells have been shown to secrete substances that inhibit HIV-1 replication in have been demonstrated without in vitro stimulation in most adults throughout all phases of disease [1, 2, 6, 11 -14]. The vitro [22 -25] . Protective and pathogenic consequences of CTL activity undoubtedly coexist in vivo and counterbalance each frequency of CTL precursors (''secondary'' CTL), however, appears to decline as HIV-1 disease advances [13, 15, 16] .
other to a certain extent. The outcome of infection (i.e., rapidity of disease progression) may, in part, depend on the predominant The presence of expanded populations of HIV-1 -specific CTL in the face of disease progression has raised the issue of role of this immune response. We have previously demonstrated that a majority (86%) of whether CTL responses contribute more to the protection of the host by limiting viral replication and spread or to the pro-HIV-1 -infected persons with hemophilia have activated, Gagspecific cytotoxic CD8 T lymphocytes in the peripheral blood. gression of disease by immunopathogenic mechanisms [17] . The effects of CTL extend beyond the cytolysis of infected Quantitation of these primary Gag-specific CTL demonstrated a frequency of 1/38,000 to 1/86,000 peripheral blood mononuclear cells (PBMC) [2, 4] . These observations have now been extended to better define the relative importance of protective and pathogenic consequences of CTL activity in the HIV-1 were infected by contaminated factor infusions, and none included when tested in parallel by use of samples (lysates of PBMC and whole blood) from single blood collections (data not shown). in this report seroconverted after 1985.
Quantitative viral RNA PCR was done by use of the Amplicor Overall, 46 subjects were studied between May 1990 and March HIV-1 Monitor assay (Roche Diagnostic Systems) with strict ad-1994. Concomitant immunologic and virologic assays were done herence to the manufacturer's protocol. The serum or EDTA-antion blood drawn during a single clinic visit. Twenty-eight subjects coagulated plasma specimens used in these assays were processed were studied at a single time point, 12 at two different time points, within 6 h of phlebotomy and stored at 080ЊC. 5 at three time points, and 1 at six time points. The duration of Cytotoxic T lymphocyte assays. Previous studies by this laboraintervals between repeat samplings ranged from 8 to 169 weeks. tory and others have demonstrated activated or primary CTL in The age of these subjects ranged from 11 to 64 years (median, the circulation of infected persons [2, 4] . Freshly isolated PBMC 30.5). The median CD4 T cell count was 324/mL, and 12 subjects were assayed in a limiting dilution format to quantitate most di-(26%) had õ200/mL at first measurement of CTL. Thirty-six subrectly the level of CTL activity. Without in vitro stimulation, these jects in this group had additional surface marker data from other measurements circumvent numerous variables that may affect the visits that enabled calculations of CD4 cell slopes (see below).
clonal expansion of CTL. Of the primary responses present, GagThirty subjects (65%) were receiving antiretroviral therapy when specific activity is the most frequently detected and was therefore first studied.
selected calculated from the number of wells that failed to exhibit 51 Cr Quantitative HIV-1 cultures. End point dilution cultures of release in excess of 3 SD above the mean of spontaneous release plasma or PBMC were done either as described by Ho et al. [26] controls. CTL frequency was estimated by the maximum likelior by the AIDS Clinical Trial Group consensus protocol (the latter hood method (statistical program provided by S. Kalams, Massawas adopted after April 1991). Plasma cultures done before April chusetts General Hospital, Boston) [30] . The HIV-1 Gag-specific 1991 were not included in the qualitative (positive vs. negative) CTL frequency was taken to be the difference between frequencies analysis of results, as the sensitivity differed from that of later calculated for activity against B-LCL targets infected with recomassays. Whole blood cultures were done as described by Alimenti binant vaccinia virus expressing HIV-1 Gag and activity against et al. [27] .
B-LCL targets infected with control vaccinia virus. HIV-1 GagPolymerase chain reaction (PCR) studies. Quantitative provispecific CTL frequency was expressed in terms of CTL/10 6 CD8-ral DNA PCR on PBMC was based on the methodology of Ou et positive T lymphocytes. al. [28] as described by Brettler et al. [29] . Dilutions of PBMC Depletion studies. For selected CTL assays, parallel limiting lysates (10 2 -10 5 cells) and 8E5 or ACH2 cell lines (2-100 copies dilution studies were done in which CD8-positive lymphocytes of the HIV-1 genome at 1 copy/cell) were processed in parallel.
were depleted from freshly isolated PBMC by use of immunomagCell lysates were subjected to 25-30 cycles of amplification with netic beads coated with anti-CD8 antibodies (Dynal, Great Neck, SK38/SK39 gag primer pairs. A 5 end-labeled SK19 probe was NY). For the assays reported, depletion of the CD8 cell population used to detect the PCR product after resolution on a 10% polyacrylexceeded 90%. amide gel. Appropriate negative controls (uninfected PBMC and CD4 cell slope calculations and statistical analyses. CD4 cell CEM cell line) were included in each assay. The highest dilution slopes were calculated by use of least squares regression analyses. at which an amplification product was detected was used for an
The absolute CD4 T cell count at the time of the CTL assay was end point readout in assays in which the controls demonstrated a designated the baseline count. All subjects with three or more sensitivity of £2 copies of HIV-1 genome. Later samples were absolute CD4 T cell values available for ú1 year after measureanalyzed by use of a modification of the Amplicor HIV-1 test ment of CTL frequency were included. The mean number of CD4 system (Roche Diagnostic Systems, Branchburg, NJ). This assay T cell determinations from which the CD4 cell slopes were calcuuses the same primers to detect HIV-1 gag sequences in DNA lated was 7.44 (range, 3-15). The mean time interval was 2.11 prepared from lysates of whole blood. Before amplification, this years (range, 1.0-4.3). DNA preparation is serially diluted. The cellular equivalents of
The relationships between Gag-specific CTL frequencies, virus DNA within each of these dilutions can be calculated from the titers, and absolute CD4 T cell counts were examined by use of complete blood count and differential white blood cell count. The
Pearson's correlation coefficient (r). Significance of the correlation HIV copy frequency in the population of lymphocytes is then coefficient was assessed with Fisher's transformation. Mean virus determined from the end point of detection. Controls are included load values for groups defined by quartiles of CTL frequency were in each assay, which ensures a sensitivity of detection of 2-5 compared by the Student's t test for independent samples. Multiple regression analysis was applied to determine the relative strengths copies of proviral DNA. These assays give comparable results JID 1997;176 (July) of relationships between continuous variables. The mean CD4 T copies/mL of plasma in positive samples (mean, 29, 567 of virus load in the circulation. There was a significant inverse correlation between the Gag-specific CTL frequency and the Results number of proviral copies measured by quantitative DNA PCR ( figure 1A ; n Å 46; r Å 0.401; Fisher's test, P Å .005). The Summary of immunologic and virologic data. Primary Gag-specific CTL frequency measurements appeared to show Gag-specific CTL frequencies ranged from 0 (no difference an inverse relationship with quantitative plasma viral RNA from background CTL frequency directed against control vaclevels, but this did not reach significance in this group of subcinia virus -infected autologous B-LCL) to 516/10 6 CD8 lymjects (figure 1B; n Å 43; r Å 0.241; P Å .120). phocytes, with a mean of 90 and a median of 68. Background
Corresponding Gag-specific CTL frequency measurements lysis of B-LCL infected with control vaccinia virus ranged for all available provirus and virus PCR measurements were from 0 to 83 CTL/10 6 lymphocytes, with a mean of 7.9 and a divided into quartiles for further analysis. The quartile of lowest median of 1. Depletion studies on selected subjects in this Gag-specific CTL frequency measurements (quartile 1) was study and those previously reported have all demonstrated Gagassociated with a mean copy frequency of proviral DNA in specific lysis to be CD8 cell -mediated (data not shown) [4] .
PBMC that was higher than for each of the remaining quartiles Virus burden was measured with a variety of assays with dif-(figure 2A). These differences were significant when quartile fering sensitivities. Plasma culture was positive in 19 (28%) 1 was compared with quartiles 2 and 3 (t test, P õ .05) but of 68 cases, and serum p24 antigen measured after immune not when quartile 1 was compared with 4 (t test, P Å .2). There complex dissociation was positive in 15 (21%) of 70 assays.
were no significant differences in mean absolute CD4 T cell Cell-associated virus titers were measurable in 58 (80.6%) of counts between these groups (data not shown). The lowest 72 samples and ranged between 1 and 3125 TCID/10 6 PBMC quartile included CTL frequencies of up to 15 Gag-specific (mean, 88). Whole blood cultures were of intermediate sensitiv-CTL/10 6 CD8 lymphocytes. A similar quartile analysis of CTL ity; 46 (73%) of 63 assays were positive. Proviral DNA was frequencies and viral RNA in plasma indicated a similar trend detectable by PCR in 47 (95.9%) of 49 samples and 36 (97.3%) (figure 2B), but differences in mean levels of viral RNA in of 37 subjects tested, and frequencies ranged from 3 to 42,000 plasma were not significant between these groups. copies/10 6 PBMC in positive samples (mean, 2345). Viral RNA Interestingly, no correlation was found between CTL activity was detectable by PCR in 46 (98%) of 47 measurements and and CD4 T cell concentration (figure 3). This suggested that 33 of 33 subjects tested, and titers ranged from 732 to 318,412 the strong relationship observed between CTL frequency and provirus load was independent of the CD4 T cell count. As would be expected, proviral DNA titers were inversely related isons were made between those with §70 and õ70 Gag-specific CTL/10 6 CD8 lymphocytes, the median CTL frequency.
NOTE. BQL Å below quantitation limit. * No./10 6 CD8 T cells.
Of the 36 subjects, those with CTL frequencies greater than † TCID/10 6 peripheral blood mononuclear cells (PBMC).
the median had a significantly slower loss of CD4 T cells ‡ TCID/mL of whole blood.
(t test, P Å .017). We reasoned that CD4 cell slopes for subjects § Proviral DNA copies/10 6 lymphocytes. x Viral RNA copies/mL of plasma.
with low baseline CD4 T cell counts (baseline defined as the / 9d2b$$jy23 05-27-97 14:33:00 jinfa UC: J Infect groups (table 2) . Furthermore, no significant difference in other parameters known to affect disease progression (baseline CD4 T cell count, age, virus load, or treatment) could be demonstrated between these groups. Similar results were obtained by use of CD4 cell slopes calculated from an interval that included all time points from 0.5 -2 years before the CTL measurement to 1 -2 years after the measurement (data not shown). This was an effort to increase the number of CD4 cell values from which slopes were derived while focusing on a time interval proximate to the CTL Figure 1 . Correlation of Gag-specific CTL frequency with proviral DNA in lymphocytes and viral RNA in plasma. A: Gag-specific CTL frequencies (no./10 6 CD8 T cells) with concurrent proviral DNA copy titers (copies/10 6 lymphocytes); n Å 46; r Å 0.401; P Å .005. B: Gag-specific CTL frequencies with concurrent viral RNA copy titers (copies/mL of plasma); n Å 43; r Å 0.241; P Å .120. first time point used for CD4 cell slope calculation) are not comparable to those with higher baseline CD4 T cell counts. For example, a loss of 100 CD4 T cells/mL/year is possible from a baseline of 500/mL but not from a baseline of 200/mL, for 3 or 4 years of follow-up. Indeed, there was a trend sug- measurement that would minimize ''plateau'' effects on CD4 lated effector cells in most persons during this phase. It has been argued that this persistent, vigorous CTL response is cell slopes as counts decline to low levels.
HIV-1 Gag -specific CTL frequency over time. Sequential partly responsible for limiting viral replication and CD4 T cell loss during this phase [2, 6]. The loss of HIV-1 -specific CTL measurements of CTL frequencies showed no consistent trends; 8 subjects demonstrated a reduction in CTL frequency over precursors as disease progresses has lent further supporting evidence to this hypothesis [13, 15, 16] . The relative lack of time, while 8 subjects demonstrated no change or an increase. Of the 3 subjects who showed a progression to AIDS (CD4 T virus-specific CTL in vertically infected children is a potential explanation for the rapid pace of progression in many of them cells õ200/mL) between measurements, only 1 had a decline in CTL frequency. This subject still had a Gag-specific CTL [36] . Other evidence that cellular immune responses are contributing to the lack of disease progression in some persons frequency of 180/10 6 CD8 T cells at a CD4 T cell count of 131/mL (a decrease from 290/10 6 CD8 T cells at a CD4 T cell was described by Cao et al. [37] , who found strong inhibition of viral replication by CD8 T cells from nonprogressors. Finally, count of 289/mL).
animal studies have correlated high levels of CTL activity against simian immunodeficiency virus with lower virus loads Discussion and an improved prognosis [38 -40] . The beneficial effects of virus-specific CTL may be counterThis study adds to the accumulating information suggesting balanced by immunopathologic effects under certain circumthat the major effects of HIV-specific CTL responses are prostances. These effects could result from direct cytolytic activity tective. Perhaps the most compelling of prior observations is the or the release of soluble factors that adversely affect uninfected temporal link between emerging CTL responses and dramatic ''bystander'' cells [19 -21, 41 -43] . Surface marker studies declines in circulating virus loads during acute infection [31, measuring the number of activated CD8 T lymphocytes with 32]. The significance of this relationship, however, has recently cytolytic capacity indicate that higher levels of such cell popubeen called into question by mathematical modeling of virus lations are correlated with a greater risk of disease progression loads in acute infection, which suggests that the decline in [44] . Furthermore, high levels of CTL activity have been assovirus load is largely a function of the availability of activated ciated with specific HIV-1 -related conditions: lymphocytic al-CD4 T cells for free virus to infect [33] .
veolitis [41] and AIDS dementia complex [42] . Analyses of Beyond the acute phase of infection is a period of relative lymph node histopathology over the course of disease have clinical quiescence. During this phase, it is now well estabdemonstrated high levels of immune activation (including CD8 lished that active viral replication is ongoing [34, 35] . Virusspecific CTL activity is also detectable by use of freshly iso-T cells with HIV-specific cytolytic capacity) in response to / 9d2b$$jy23 05-27-97 14:33:00 jinfa UC: J Infect persistent viral replication and trapping in the lymphoid tissues was demonstrated in only 11 of 25 persons studied. Our results demonstrate an inverse relationship between primary Gag-spe- [45] . These pathologic changes occur early and progress to destruction of the lymphoid architecture and the ultimate loss cific CTL levels and virus load. While it seems more likely that CTL activity is limiting viral replication, it is acknowlof responsiveness to pathogens. It is not clear to what extent disease progression is attributable to viral replication itself [34, edged that the converse may be true: Active viral replication might be limiting activation of CTL. Arguing against the latter 35] or to the virus-specific cellular immune response.
Overall, our results support the concept that HIV-1 -specific possibility are in vitro studies in which CTL clones or CD8 T cells from infected persons are combined with actively infected CTL responses are primarily protective. Our observations complement and expand on those of previous reports. Rinaldo et CD4 T cells [37] . In such assays, it is readily demonstrated that there is a reduction in viral replication in a dose-dependent al.
[13] demonstrated a lack of association of primary Gagspecific CTL activity (in freshly isolated PBMC) with disease manner. In vivo, the most compelling data that CTL limit viral replication is derived from infusion studies of a Nef-specific stage while showing a lower level of secondary (CTL precursor frequency) activity in persons with advanced disease compared CTL clone, which led to the appearance of virus lacking the epitope for which the clone was specific [47] . Such direct with those with long-term nonprogressive infection. Virus load was tested but not correlated directly with CTL activity. From evidence of virus escape from CTL activity argues strongly for the concept that CTL activity inhibits viral replication. these results, it was concluded that the level of primary CTL activity is not significantly correlated with disease progression.
Finally, the lack of Gag-specific CTL activity in freshly isolated PBMC has been correlated with disease progression We have, in this report, similarly shown a lack of correlation between primary CTL activity and disease stage (CD4 cell to AIDS or AIDS-related complex in a study by Riviere et al. [48] . Our analysis provides quantitative measures of both Gagcount) in a cross-sectional analysis. The longitudinal, prospective analysis of CD4 T cell loss over time, however, has allowed specific CTL and surrogate markers of disease progression that support this finding. a clearer demonstration of the role of CTL and a different interpretation: that primary CTL activity is inversely correlated No strong correlation between the absolute CD4 T cell counts and frequency of circulating CTL was found in our with disease progression. Furthermore, our analysis of the relationship between virus load and Gag-specific CTL frequencies cross-sectional analysis of these persons with hemophilia, as others have shown previously in other cohorts [13, 49] . Furtherwould argue that this immune response is limiting disease progression regardless of the CD4 T cell concentration. more, in this series, no clear trends in CTL frequency over time were observed in 16 persons for whom there was more Our results are also consistent with the findings of Kundu and Merigan [46] , who demonstrated a significant inverse assothan one determination. These data demonstrate that a decline in primary CTL activity is not seen over the course of disease. ciation between the Env-specific CTL activity and proviral copy numbers in asymptomatic persons. In that study, however, High CTL frequencies are observed in some persons with advanced disease. Studies that have demonstrated a decline of proviral copy frequencies were correlated with qualitative (positive or negative) Env-specific responses, since such activity CTL activity with loss of CD4 elicit HIV-1 specific CTL and, in particular, Gag-specific CTL. 
